In the News: Partek Press Releases

St. Louis, Missouri – November 20, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to Kuwait University (KU).

The Health Sciences Center at KU will use Partek GS for a variety of applications. Kuwait University, located in Kuwait City. Partek GS allows for thorough analysis of gene expression, exon alternative splicing, copy number, genome-wide SNP, and ChIP-chip regulation data within in the same software package. In addition, Partek GS provides easy to use workflows to walk through the analysis process. Partek GS is Affymetrix GeneChip-compatible^TM for gene expression analysis, exon expression analysis, chromosomal copy number analysis, tiling array analysis, and chromosomal copy number analysis of high density SNP arrays.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

St. Louis, Missouri – November 14, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to Erasmus Medical Center (Erasmus MC).

Erasmus MC has recently expanded the number of Partek licenses in use at the facility. Located in Rotterdam, The Netherlands, Erasmus MC is a first class research hospital that also includes the Erasmus MC – Sophia hospital for children and the Erasmus MC – Daniel den Hoed Cancer Center.

Partek GS allows for thorough analysis of gene expression, exon alternative splicing, copy number, genome-wide SNP, and ChIP-chip regulation data within in the same software package. In addition, Partek GS provides easy to use workflows to walk through the analysis process. Partek GS is Affymetrix GeneChip-compatible^TM for gene expression analysis, exon expression analysis, chromosomal copy number analysis, tiling array analysis, and chromosomal copy number analysis of high density SNP arrays.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

St. Louis, Missouri – November 13, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to Roche Molecular Diagnostics (Roche).

Researchers at Roche Molecular Diagnostics will use Partek GS to analyze diagnostic data from a variety of studies involving drug development. Current research at Roche involves using biomarkers to determine patients’ reactions to specific medications, as well as drug discovery. Roche, a leader in the pharmaceutical industry, has provided such therapeutic drugs as Tamiflu^®, Herceptin^®, and Boniva^®.

Partek GS allows for thorough analysis of gene expression, exon alternative splicing, copy number, genome-wide SNP, and ChIP-chip regulation data within in the same software package. In addition, Partek GS provides easy to use workflows to walk through the analysis process. Partek GS is Affymetrix GeneChip-compatible^TM for gene expression analysis, exon expression analysis, chromosomal copy number analysis, tiling array analysis, and chromosomal copy number analysis of high density SNP arrays.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

St. Louis, Missouri – November 12, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to the University of Maryland.

Partek GS will be used throughout the campus of the University of Maryland. Researchers at the School of Medicine will use Partek GS to analyze data from current studies on genetic variation in schizophrenia. In another area of campus, researchers at the School of Nursing are using Partek GS to analyze data from research on chronic pain. The University of Maryland is located in College Park.

Partek GS software provides powerful statistical analysis integrated with interactive data visualization and is designed to efficiently process large volumes of high-dimensional genomic/proteomic data. Partek GS allows for thorough analysis of gene expression, exon alternative splicing, copy number, genome-wide SNP, and ChIP-chip regulation data within in the same software package. In addition, Partek GS provides easy to use workflows to walk through the analysis process. Partek GS is Affymetrix GeneChip-compatible^TM for gene expression analysis, exon expression analysis, chromosomal copy number analysis, tiling array analysis, and chromosomal copy number analysis of high density SNP arrays.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

St. Louis, Missouri – November 12, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to the Korean National Genome Research Institute.

Researchers at the Institute will analyze genomic data with Partek GS. The Institute is part of the Korea National Institute of Health. Partek GS software provides powerful statistical analysis integrated with interactive data visualization and is designed to efficiently process large volumes of high-dimensional genomic/proteomic data.

Partek GS allows for thorough analysis of gene expression, exon alternative splicing, copy number, genome-wide SNP, and ChIP-chip regulation data within in the same software package. In addition, Partek GS provides easy to use workflows to walk through the analysis process. Partek GS is Affymetrix GeneChip-compatible^TM for gene expression analysis, exon expression analysis, chromosomal copy number analysis, tiling array analysis, and chromosomal copy number analysis of high density SNP arrays.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

St. Louis, Missouri – November 12, 2007 – Partek Incorporated announced today that Cardiff University has renewed their license agreement for Partek^® Genomics Suite^TM (Partek GS) software.

Cardiff University, located in Wales, was founded in 1883. Partek GS allows for thorough analysis of gene expression, exon alternative splicing, copy number, genome-wide SNP, and ChIP-chip regulation data within in the same software package. In addition, Partek GS provides easy to use workflows to walk through the analysis process. Partek GS is Affymetrix GeneChip-compatible^TM for gene expression analysis, exon expression analysis, chromosomal copy number analysis, tiling array analysis, and chromosomal copy number analysis of high density SNP arrays.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

St. Louis, Missouri – November 06, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to the Institut d´Investigacions Biomediques August Pi I Sunyer (IDIBAPS).

Researchers at the IDIBAPS will use Partek GS to analyze data while striving to meet their research goals. The IDIBAPS was founded in 1993 as a collaboration between several medical universities and research institutions, including the University of Barcelona School of Medicine and the Research and the Information Society (DURSI). The Institute has five main areas of research that include biological aggression and response mechanisms, respiratory, cardiovascular, and renal pathobiology, liver, digestive system, and metabolism, clinical and experimental neurosciences, and oncology and hematology.

Partek GS software provides powerful statistical analysis integrated with interactive data visualization and is designed to efficiently process large volumes of high-dimensional genomic/proteomic data. Partek GS allows for thorough analysis of gene expression, exon alternative splicing, copy number, genome-wide SNP, and ChIP-chip regulation data within in the same software package. In addition, Partek GS provides easy to use workflows to walk through the analysis process. Partek GS is Affymetrix GeneChip-compatible^TM for gene expression analysis, exon expression analysis, chromosomal copy number analysis, tiling array analysis, and chromosomal copy number analysis of high density SNP arrays.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.

St. Louis, Missouri – November 06, 2007 – Partek Incorporated announced today that it has licensed Partek^® Genomics Suite^TM (Partek GS) software to the University of Chicago.

Researchers within the Psychiatry Department at the University will use Partek GS to analyze gene expression data from studies involving the genetic markers of mental illness. The University of Chicago was founded, in part, by John D. Rockefeller in 1890.

Partek GS software provides powerful statistical analysis integrated with interactive data visualization and is designed to efficiently process large volumes of high-dimensional genomic/proteomic data. Partek GS allows for thorough analysis of gene expression, exon alternative splicing, copy number, genome-wide SNP, and ChIP-chip regulation data within in the same software package. In addition, Partek GS provides easy to use workflows to walk through the analysis process. Partek GS is Affymetrix GeneChip-compatible^TM for gene expression analysis, exon expression analysis, chromosomal copy number analysis, tiling array analysis, and chromosomal copy number analysis of high density SNP arrays.

Partek Incorporated is a leading provider of statistical analysis and interactive data visualization software for the scientific research community. Partek software enables researchers to quickly identify and quantify patterns in data, including data resulting from genomic and proteomic studies, high-throughput screening campaigns, and computer aided drug design. Partek is located in St. Louis, Missouri.